期刊文献+

Survivin在喉鳞癌组织中表达及其与临床相关因素的关系 被引量:6

Survivin Expression in Laryngeal Squamous Cell Carcinoma and its Relationship with Clinical Factors
下载PDF
导出
摘要 背景与目的:survivin是凋亡抑制蛋白家族的一个新成员。survivin在大多数肿瘤中有表达,但在成人终末分化组织中一般不表达或低表达。本研究检测喉鳞癌组织中survivin的表达,分析其与喉鳞癌患者年龄、性别、临床分期、T分期、N分期、喉癌分型、病理分化、复发以评价其与预后的相关性。方法:收集1997年1月~1998年12月我院收治的81例喉鳞癌患者的临床资料和石蜡块,制作组织芯片,用链霉素亲生物素-过氧化物酶法(SP)检测肿瘤组织和周围正常喉粘膜的survivin表达;统计学分析采用SPSS10.0软件,采用Kaplan-Meier法进行生存分析并进行log-rank检验,因素间的相关关系采用χ2检验,多因素分析采用Cox模型。结果:本组喉鳞癌患者总的5年生存率约58.33%;survivin在喉鳞癌和正常喉组织中的表达阳性率分别为50.62%,0%,(P<0.05);survivin表达阳性组(5年生存率22.06%;复发率43.90%)较阴性组(5年生存率92.33%;复发率12.50%)预后差(P<0.05);单因素分析显示:临床分期、T分期、N分期、病理分级、复发、survivin阳性表达是影响患者预后的主要因素(P<0.05);χ2检验显示:survivin表达与临床分期、T分期、N分期、病理分化、复发相关(P<0.05);多因素分析显示:survivin表达、临床分期、复发是喉癌独立的预后因素。结论:survivin表达? BACKGROUND &OBJECTIVE: Survivin, a new described member of the f am ily of apoptosis inhibitory proteins (IAP), is undetectable in normal tissue of adults, but abundantly expressed in a variety of human malignancies. This study was designed to examine the expression of Survivin in laryngeal squamous cell ca rcinoma, analyze the relationships between the expression of Survivin and progno stic factors including age, gender, clinical stage, T stage, N stage, classifica tion, histology and recurrence, to investigate its significance on prognosis. ME THODS:Clinical information and paraffin-embedded tumor samples of 81 cases lary ngeal squamous cell carcinoma(LSCC) patients, who were treated at Cancer Center of Sun Yat-sen University between 1997 and 1998, were collected. Tissue chip wa s made, and SP method was performed to analyze Survivin expression in tumor tiss ue and adjacent normal laryngeal mucosa. SPSS 10.0 software was used. Kaplan-Me ier method was used for survival analysis, and log-rank test was used for data analysis; multivariate analysis was carried out using Cox proportional hazard mo del. RESULTS: The overall 5-year survival rate for patients with laryngeal squa mous cell carcinoma in this study was 58.33%. The over-expression rate of Surv ivin in tumor tissue and adjacent normal laryngeal tissue were 50.62%, 0%, res pectively (P< 0.05). The positive Survivin expression group(5-year overall s urivial rate: 22.06%)had a worse prognosis than that of negative group (5-yea r overall survival rate: 92.33%)(P< 0.05). The univariate analysis showed tha t clinical stage, T stage, N stage, histology grade, recurrence, and Survivin ex pression were the most important prognostic factors (P< 0.05). The clinical stage, T stage, N stage, histology grade and recurrence(P< 0.05); Multivariate analys is results showed that clinical stage, survivin expression, and recurrence were independent prognosis factors on survival in LSCC patients. CONCLUSIONS: The exp ression of Survivin is an important biological factor affecting the prognosis; T issue chip method can be simply and efficiently used in large scale of retrospec tive study in laryngeal squamous cell carcinoma.
出处 《癌症》 SCIE CAS CSCD 北大核心 2004年第z1期1493-1497,共5页 Chinese Journal of Cancer
关键词 喉肿瘤 SURVIVIN 组织芯片 预后 Laryngeal squamous cell carcinoma Survivin Tissue Chip
  • 相关文献

参考文献13

  • 1[2]Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma [J]. Nat Med,1997, 3(8):917-921.
  • 2[3]Hinds MG, Norton RS, Vaux DL, et al. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat [J]. Nat Struct Biol, 1999, 6(7):648-651.
  • 3[4]Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoiut by survivin [J]. Nature, 1998, 396(6711): 580-584.
  • 4[5]Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer [J]. Br J Cancer, 2003,88(7): 1077 - 1083.
  • 5[6]Kappler M, Kotzsch M, Bartel F, et al. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival [J]. Clin Cancer Res, 2003, 9(3): 1098 - 1104.
  • 6[7]Lo Muzio L, Staibano S, Pannone G, et al. Expression of theapoptosis inhibitor survivin in aggressive squamous cell carcinoma [J]. Exp MolPathol, 2001, 70(3):249-254.
  • 7王梅,王冰,王晓丽,莫立平,任娟,李明众.凋亡相关基因survivin在子宫颈癌组织中的表达及其与bcl-2、p53基因表达相关性的初步研究[J].中华妇产科杂志,2001,36(9):546-548. 被引量:76
  • 8[9]Dong Y, Sui L, Watanabe Y, Sugimoto K, et al. Survivin expression in laryngeal squmous cell carciuomas and its prognostic implications [J]. Anti Res. 2002, 22(4): 2377-2383.
  • 9陈艳峰,陈福进,杨安奎,曾宗渊,宋明,李秋梨.复发性喉癌患者的临床特点和影响预后因素的分析[J].癌症,2004,23(5):584-588. 被引量:9
  • 10[11]Swana HS, Grossman D, Anthony JN, et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer [J]. NEnglJ Med, 1999, 341(6):452 -453.

二级参考文献26

  • 1Grossman D,J Invest Dermatol,1999年,113卷,1076页
  • 2Grossman D,Lab Invest,1999年,79卷,1121页
  • 3Li F,Nature,1998年,396卷,580页
  • 4Deveraux Q L,Nature,1997年,388卷,300页
  • 5洪明晃 闵华庆 见:闵华庆 主编.鼻咽癌临床分期[A].见:闵华庆,主编.鼻咽癌研究[C].广东:广东科技出版社,1998.178-190.
  • 6Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications dur i ng prostate cancer progression by high-throughput fluorescence in situ hybridiz ation on tissue microarrays. Cancer Res, 1999, 59: 803-806.
  • 7王力红 姚莉 张尚福 等.p16蛋白在鼻咽癌中的表达及与预后的关系[J].华西医科大学学报,1999,30:394-396.
  • 8Shibosawa E,Tsutsumi K,Koizuka I,et al. Absence of nuclear p16 from Epstein- Barr virus-associated undifferentiated nasopharyngeal carcinomas. Laryngoscope ,2000,110:93-97.
  • 9Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microar rays for high-th roughput molecular profiling of tumor specimens. Nature Med, 1998, 4: 844-847 .
  • 10Richter J, Wagner U, Kononen J, et al. High-throughput tiss ue microarray analy sis of cyclin E gene amplification and overexpression in urinary bladder cancer . Am J Pathol, 2000, 157: 787-794.

共引文献99

同被引文献66

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部